1型糖尿病女性循环内皮祖细胞水平与性功能的变化
一项病例对照观察研究纳入36例1型糖尿病女性和64例年龄匹配的健康对照,在月经周期卵泡期、排卵期和黄体期检测内皮祖细胞水平并评估性功能。结果显示,1型糖尿病女性在排卵期CD34+和CD34+CD133+细胞水平显著低于对照,排卵期和黄体期CD34+KDR+细胞水平也显著低于对照,且各期FSFI总分更低、FSDS评分更高;内皮祖细胞计数可预测该人群的性功能。
要点
- 1型糖尿病女性排卵期CD34+和CD34+CD133+细胞水平显著低于健康对照(P < .001)。
- 1型糖尿病女性排卵期和黄体期CD34+KDR+细胞水平均显著低于对照(P < .001)。
- 1型糖尿病女性月经周期各期FSFI总分更低、FSDS评分更高,内皮祖细胞计数可预测性功能。
核心结论
- 1型糖尿病女性在月经周期中内皮祖细胞水平低于健康对照。
- 内皮祖细胞计数可预测该特定人群的性功能。
研究设计与样本
- 病例对照观察研究,在那不勒斯「Luigi Vanvitelli」大学医院内分泌与代谢病科开展。
- 纳入36例1型糖尿病女性和64例年龄匹配的健康对照。
- 采用流式细胞术定量内皮祖细胞,用女性性功能指数(FSFI)和女性性困扰量表评估性功能。
- 所有评估均在同一月经周期的卵泡期、排卵期和黄体期进行。
主要发现
- 与对照相比,1型糖尿病女性排卵期CD34+细胞(P < .001)和CD34+CD133+细胞(P < .001)水平显著降低。
- 与对照相比,1型糖尿病女性排卵期和黄黄体期CD34+KDR+细胞水平均显著降低(两项P < .001)。
- 1型糖尿病女性在月经周期所有阶段的FSFI总分显著低于对照,FSDS评分显著高于对照。
- 卵泡期FSFI总分由CD34+CD133+和CD34+KDR+细胞预测,排卵期由CD34+和CD34+KDR+CD133+细胞预测,黄体期由CD34+KDR+和CD34+KDR+CD133+细胞预测。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Endothelial progenitor cells (EPCs), which are involved in the mechanisms of vascular repair and sexual function, are decreased in diabetic women compared with general population. OBJECTIVE: This work aimed to investigate the circulating levels of EPCs and the change in sexual function during the menstrual cycle in women with type 1 diabetes (T1DM) compared with healthy women. METHODS: This case-control observational study was conducted at the Unit of Endocrinology and Metabolic Diseases at University Hospital "Luigi Vanvitelli'' of Naples. Participants included 36 women with T1DM and 64 age-matched healthy controls. EPCs were quantified by flow cytometry and sexual function was assessed using the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale. All assessments were made at the follicular, ovulatory, and luteal phases of the same menstrual cycle. Main outcome measures included differences in EPCs levels and sexual function between patients and controls. RESULTS: Compared with controls, women with T1DM showed significantly lower levels of both CD34 + (P < .001) and CD34 + CD133 + cells (P < .001) in the ovulatory phase, and CD34 + KDR + cells both in the ovulatory phase and in the luteal phase (P < .001 for both). Diabetic women showed significantly lower total FSFI scores and higher FSDS score than control women in all phases of the menstrual cycle. FSFI total score was predicted by both CD34 + CD133 + and CD34 + KDR + cells in the follicular phase, CD34 + and CD34 + KDR + CD133 + cells in the ovulatory phase, and CD34 + KDR + and CD34 + KDR + CD133 + cells in the luteal phase. CONCLUSION: Women with T1DM show lower levels of EPCs during the menstrual cycle compared with controls. EPCs count predicts sexual function in this selected population.
引用
- Maio A, Maiorino MI, Longo M, et al. Change in Circulating Levels of Endothelial Progenitor Cells and Sexual Function in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2022. PMID: 35583559. doi:10.1210/clinem/dgac316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。